Renaissance Technologies
AURA icon

Renaissance Technologies’s Aura Biosciences AURA Stock Holding History

Renaissance Technologies’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
174,200
+72,100
+71% +$516K ﹤0.01% 2207
2026
Q1 		$683K Sell
102,100
-43,100
-30% -$247K ﹤0.01% 2458
2025
Q4 		$791K Buy
145,200
+47,592
+49% +$283K ﹤0.01% 2382
2025
Q3 		$603K Sell
97,608
-33,940
-26% -$222K ﹤0.01% 2716
2025
Q2 		$823K Buy
131,548
+28,248
+27% +$165K ﹤0.01% 2601
2025
Q1 		$605K Buy
103,300
+19,600
+23% +$148K ﹤0.01% 2663
2024
Q4 		$688K Buy
83,700
+69,500
+489% +$654K ﹤0.01% 2689
2024
Q3 		$127K Sell
14,200
-57,900
-80% -$496K ﹤0.01% 3218
2024
Q2 		$545K Buy
72,100
+15,000
+26% +$110K ﹤0.01% 2658
2024
Q1 		$448K Buy
57,100
+28,600
+100% +$237K ﹤0.01% 2909
2023
Q4 		$253K Buy
28,500
+15,000
+111% +$127K ﹤0.01% 3049
2023
Q3 		$121K Sell
13,500
-6,000
-31% -$64.5K ﹤0.01% 3206
2023
Q2 		$241K Buy
19,500
+9,400
+93% +$100K ﹤0.01% 3223
2023
Q1 		$94K Sell
10,100
-3,000
-23% -$31.2K ﹤0.01% 3507
2022
Q4 		$138K Buy
+13,100
New +$167K ﹤0.01% 3532

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies's AURA Position: Q2 2026 in Review

Renaissance Technologies increased its Aura Biosciences (AURA) stake by 71% in Q2 2026, buying an estimated $516K and bringing the position to 174,200 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2207.

Renaissance Technologies first reported a position in AURA in Q4 2022 and has held it in 15 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Renaissance Technologies held 174,200 shares of Aura Biosciences worth $1.24M as of Q2 2026.
  • Renaissance Technologies bought 72,100 Aura Biosciences shares in Q2 2026, an estimated $516K.
  • Aura Biosciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2207 holding.
  • Renaissance Technologies first reported a position in Aura Biosciences in Q4 2022 and has held it in 15 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.